These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26013569)

  • 1. Post-marketing monitoring of intussusception after rotavirus vaccination in Japan.
    Bauchau V; Van Holle L; Mahaux O; Holl K; Sugiyama K; Buyse H
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):765-70. PubMed ID: 26013569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
    Singh T; Delannois F; Haguinet F; Molo LY
    Drug Saf; 2022 Feb; 45(2):155-168. PubMed ID: 35015268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico.
    Velázquez FR; Colindres RE; Grajales C; Hernández MT; Mercadillo MG; Torres FJ; Cervantes-Apolinar M; DeAntonio-Suarez R; Ortega-Barria E; Blum M; Breuer T; Verstraeten T
    Pediatr Infect Dis J; 2012 Jul; 31(7):736-44. PubMed ID: 22695189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.
    Buttery JP; Danchin MH; Lee KJ; Carlin JB; McIntyre PB; Elliott EJ; Booy R; Bines JE;
    Vaccine; 2011 Apr; 29(16):3061-6. PubMed ID: 21316503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis.
    Ledent E; Lieftucht A; Buyse H; Sugiyama K; Mckenna M; Holl K
    Drug Saf; 2016 Mar; 39(3):219-30. PubMed ID: 26748506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022.
    Anwari P; Burnett E; Chavers TP; Samsor A; Safi H; Safi N; Clark AD; Parashar UD; Tate JE
    Vaccine; 2024 Mar; 42(8):2059-2064. PubMed ID: 38413278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies.
    Rosillon D; Buyse H; Friedland LR; Ng SP; Velázquez FR; Breuer T
    Pediatr Infect Dis J; 2015 Jul; 34(7):763-8. PubMed ID: 26069948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.
    Haber P; Parashar UD; Haber M; DeStefano F
    Vaccine; 2015 Sep; 33(38):4873-7. PubMed ID: 26276687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intussusception following rotavirus vaccination: an updated review of the available evidence.
    Rha B; Tate JE; Weintraub E; Haber P; Yen C; Patel M; Cortese MM; DeStefano F; Parashar UD
    Expert Rev Vaccines; 2014 Nov; 13(11):1339-48. PubMed ID: 25066368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
    Carlin JB; Macartney KK; Lee KJ; Quinn HE; Buttery J; Lopert R; Bines J; McIntyre PB
    Clin Infect Dis; 2013 Nov; 57(10):1427-34. PubMed ID: 23964090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa.
    Groome MJ; Tate JE; Arnold M; Chitnis M; Cox S; de Vos C; Kirsten M; le Grange SM; Loveland J; Machaea S; Maharaj A; Andrews N; Madhi SA; Parashar UD
    Clin Infect Dis; 2020 Apr; 70(8):1606-1612. PubMed ID: 31125061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea.
    Kim KY; Kim DS
    Yonsei Med J; 2017 May; 58(3):631-636. PubMed ID: 28332371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intussusception after Rotavirus Vaccine Introduction in India.
    Reddy SN; Nair NP; Tate JE; Thiyagarajan V; Giri S; Praharaj I; Mohan VR; Babji S; Gupte MD; Arora R; Bidari S; Senthamizh S; Mekala S; Goru KB; Reddy B; Pamu P; Gorthi RP; Badur M; Mohan V; Sathpathy S; Mohanty H; Dash M; Mohakud NK; Ray RK; Mohanty P; Gathwala G; Chawla S; Gupta M; Gupta R; Goyal S; Sharma P; Mathew MA; Jacob TJK; Sundaram B; Purushothaman GKC; Dorairaj P; Jagannatham M; Murugiah K; Boopathy H; Maniam R; Gurusamy R; Kumaravel S; Shenoy A; Jain H; Goswami JK; Wakhlu A; Gupta V; Vinayagamurthy G; Parashar UD; Kang G
    N Engl J Med; 2020 Nov; 383(20):1932-1940. PubMed ID: 33176083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.
    Hoffman V; Abu-Elyazeed R; Enger C; Esposito DB; Doherty MC; Quinlan SC; Skerry K; Holick CN; Basile P; Friedland LR; Praet N; Wéry S; Willame C; Dore DD; Rosillon D
    Hum Vaccin Immunother; 2018 Jul; 14(7):1782-1790. PubMed ID: 29533129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A benefit-risk analysis of rotavirus vaccination, France, 2015.
    Lamrani A; Tubert-Bitter P; Hill C; Escolano S
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.
    Tate JE; Mwenda JM; Armah G; Jani B; Omore R; Ademe A; Mujuru H; Mpabalwani E; Ngwira B; Cortese MM; Mihigo R; Glover-Addy H; Mbaga M; Osawa F; Tadesse A; Mbuwayesango B; Simwaka J; Cunliffe N; Lopman BA; Weldegebriel G; Ansong D; Msuya D; Ogwel B; Karengera T; Manangazira P; Bvulani B; Yen C; Zawaira FR; Narh CT; Mboma L; Saula P; Teshager F; Getachew H; Moeti RM; Eweronu-Laryea C; Parashar UD;
    N Engl J Med; 2018 Apr; 378(16):1521-1528. PubMed ID: 29669224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intussusception risk after rotavirus vaccination in U.S. infants.
    Yih WK; Lieu TA; Kulldorff M; Martin D; McMahill-Walraven CN; Platt R; Selvam N; Selvan M; Lee GM; Nguyen M
    N Engl J Med; 2014 Feb; 370(6):503-12. PubMed ID: 24422676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.